JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB267078

Human SIDT1 knockout A549 cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SIDT1 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 11 and 1 bp insertion in exon 11 and 2 bp deletion in exon 11.

View Alternative Names

AW045928, B830021E24Rik, FLJ20174, Msid2, OTTMUSP00000032144, SID 1, SID1 transmembrane family member 1, SIDT1_HUMAN

3 Images
Sanger Sequencing - Human SIDT1 knockout A549 cell line (AB267078)
  • Sanger seq

Unknown

Sanger Sequencing - Human SIDT1 knockout A549 cell line (AB267078)

Allele-2 : 1 bp deletion in exon 11.

Sanger Sequencing - Human SIDT1 knockout A549 cell line (AB267078)
  • Sanger seq

Unknown

Sanger Sequencing - Human SIDT1 knockout A549 cell line (AB267078)

Allele-1 : 2 bp deletion in exon11

Sanger Sequencing - Human SIDT1 knockout A549 cell line (AB267078)
  • Sanger seq

Unknown

Sanger Sequencing - Human SIDT1 knockout A549 cell line (AB267078)

Allele-3 : 1 bp insertion in exon 11.

Key facts

Cell type

A549

Species or organism

Human

Tissue

Lung

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 11 and 1 bp insertion in exon 11 and 2 bp deletion in exon 11

Disease

Carcinoma

Product details

Recommended control: Human wild-type A549 cell line (ab255450). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267078-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267078 Human SIDT1 knockout A549 cell line", "number":"AB267078-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab267078-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab267078 Human SIDT1 knockout A549 cell line", "number":"AB267078-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SIDT1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
  • Do not allow the cell density to exceed 7x104 cells/cm2.
Culture medium

F-12K + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The SID1 transmembrane family member 1 (SIDT1) protein is involved in the transport of small interfering RNA (siRNA) across cellular membranes. SIDT1 is also known as SID-1 homolog 1 or SID-1 transmembrane family member 1 and it has a mass of approximately 89 kDa. It is expressed in various tissues with notable expression in the placenta and kidney suggesting its functional significance in these locations.
Biological function summary

SIDT1 is involved in the RNA interference (RNAi) pathway which regulates gene expression. This protein is not known to form parts of larger protein complexes but serves as a channel for dsRNA molecules. SIDT1's activity can affect gene silencing processes by facilitating the entry of siRNA from the extracellular environment into the cell cytoplasm playing an important role in post-transcriptional gene regulation.

Pathways

SIDT1 plays a role in the RNA interference pathway important for post-transcriptional regulation of genes. It is associated with the machinery of RNAi which includes Dicer and Argonaute proteins. These interactions are important because they allow for precise gene expression control. SIDT1 facilitates the cellular uptake of siRNA thereby influencing gene expression levels and impacting regulatory pathways tied to cellular homeostasis.

SIDT1 has potential links to disorders involving aberrant gene expression such as certain carcinomas. Its role in enabling RNAi makes it a subject of interest in cancer research where dysregulated gene silencing mechanisms may contribute to disease. Connections between SIDT1 and other proteins like Argonaute in these disease processes provide avenues for therapeutic exploration making SIDT1 a target for interventions aiming to modulate RNAi-related pathways in cancer therapy.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 1 US: 1

Adherent/suspension

Adherent

Gender

Male

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com